Everolimus stent proves effective.
SoRelle
Ruth
R
D000293:Adolescent; D017668:Age of Onset; D002309:Cardiology; D002648:Child; D023903:Coronary Restenosis / Q000517:prevention & control; D003971:Diastole; D004343:Drug Implants; D000068338:Everolimus; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D011183:Postoperative Complications / Q000401:mortality; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D015607:Stents; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D004343:Drug Implants; D000960:Hypolipidemic Agents; D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus